Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertoletti

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patientsAkeel Alisa, Annette Ives, Ansar A Pathan, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2018
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8<sup>+</sup> T cells to Tc1 phenotypeBhushan Dharmadhikari, Emily Nickles, Zulkarnain Harfuddin, et al.
The Journal of Clinical Investigation|July 25, 2017
Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infectionJanine Kah, Sarene Koh, Tassilo Volz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responsesDelia Goletti, Linda Petrone, Davide Manissero, et al.
Journal of Hepatology|February 26, 2015
Reply to: "To target or not to target viral antigens in HBV related HCC?"Waseem Qasim, Maurizia Brunetto, Adam J Gehring, et al.
Gastroenterology|April 6, 2012
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cellsElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Journal of Virology|February 26, 2005
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infectionOrnella Franzese, Patrick T F Kennedy, Adam J Gehring, et al.
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Sources of diversity in T cell epitope discoveryCynthia Xin Lei Chang, Lingyun Dai, Zhen Wei Tan, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 12, 2021
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronavirusesCedric C S Tan, Christopher J Owen, Christine Y L Tham, et al.
Cellular & Molecular Immunology|July 27, 2010
Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothersLemonica Koumbi, Antonio Bertoletti, Vassiliki Anastasiadou, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patientsAkeel Alisa, Annette Ives, Ansar A Pathan, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2018
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8<sup>+</sup> T cells to Tc1 phenotypeBhushan Dharmadhikari, Emily Nickles, Zulkarnain Harfuddin, et al.
The Journal of Clinical Investigation|July 25, 2017
Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infectionJanine Kah, Sarene Koh, Tassilo Volz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responsesDelia Goletti, Linda Petrone, Davide Manissero, et al.
Journal of Hepatology|February 26, 2015
Reply to: "To target or not to target viral antigens in HBV related HCC?"Waseem Qasim, Maurizia Brunetto, Adam J Gehring, et al.
Gastroenterology|April 6, 2012
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cellsElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Journal of Virology|February 26, 2005
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infectionOrnella Franzese, Patrick T F Kennedy, Adam J Gehring, et al.
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Sources of diversity in T cell epitope discoveryCynthia Xin Lei Chang, Lingyun Dai, Zhen Wei Tan, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 12, 2021
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronavirusesCedric C S Tan, Christopher J Owen, Christine Y L Tham, et al.
Cellular & Molecular Immunology|July 27, 2010
Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothersLemonica Koumbi, Antonio Bertoletti, Vassiliki Anastasiadou, et al.
Pageof 23